78998 Federal Register / Vol. 75, No. 242 / Friday, December 17, 2010 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Addressing 

Global TB Prevention and Control in all 

Populations and Strengthening Health 

Facilities, Laboratories, Prisons and 

Other Community Settings, Funding 

Opportunity Announcement (FOA) 

PS11–002; and Addressing TB Control 

and Lung Health Activities through the 

Vietnam National Lung Hospital/ 

National TB Program (NLH/NTP), FOA 

PS11–004, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

TIME AND DATE: 12 p.m.—2 p.m., March 

10, 2011 (Closed). 

PLACE: Teleconference. 

STATUS: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

MATTERS TO BE DISCUSSED: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Addressing Global TB Prevention and 

Control in all Populations and 

Strengthening Health Facilities, 

Laboratories, Prisons And Other 

Community Settings, FOA PS11–002’’ 

and ‘‘Addressing TB Control and Lung 

Health Activities through the Vietnam 

National Lung Hospital/National TB 

Program (NLH/NTP), FOA PS11–004, 

initial review.’’ 

CONTACT PERSON FOR MORE INFORMATION: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road, NE., Mailstop E60, 

Atlanta, Georgia 30333, Telephone: 

(404) 498–2293. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 13, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–31798 Filed 12–16–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee on Procedures Review, 

Advisory Board on Radiation and 

Worker Health (ABRWH), National 

Institute for Occupational Safety and 

Health (NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned subcommittee: 

Time and Date: 9 a.m.–5 p.m., January 

5, 2011. 

Place: Cincinnati Airport Marriott, 

2395 Progress Drive, Hebron, Kentucky 

41018. Telephone (859) 334–4611, Fax 

(859) 334–4619. 

Status: Open to the public, but 

without a public comment period. To 

access by conference call, dial the 

following information: (866) 659–0537, 

Participant Pass Code 9933701. 

Background: The ABRWH was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

compensation program. Key functions of 

the ABRWH include providing advice 

on the development of probability of 

causation guidelines that have been 

promulgated by the Department of 

Health and Human Services (HHS) as a 

final rule; advice on methods of dose 

reconstruction which have also been 

promulgated by HHS as a final rule; 

advice on the scientific validity and 

quality of dose estimation and 

reconstruction efforts being performed 

for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special 

Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the ABRWH to 

HHS, which subsequently delegated this 

authority to CDC. NIOSH implements 

this responsibility for CDC. The charter 

was issued on August 3, 2001, renewed 

at appropriate intervals, and will expire 

on August 3, 2011. 

Purpose: The ABRWH is charged with 

(a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) 

providing advice to the Secretary, HHS, 

on the scientific validity and quality of 

dose reconstruction efforts performed 

for this program; and (c) upon request 

by the Secretary, HHS, advising the 

Secretary on whether there is a class of 

employees at any Department of Energy 

facility who were exposed to radiation 

but for whom it is not feasible to 

estimate their radiation dose, and on 

whether there is a reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. The Subcommittee on 

Procedures Review was established to 

aid the ABRWH in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstructions. The Subcommittee on 

Procedures Review is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor. 

Matters To Be Discussed: The agenda 

for the Subcommittee meeting includes: 

Review of draft prototype documents for 

informing the public on completed 

Subcommittee procedure reviews; 

discussion of the following ORAU & 

OCAS procedures: ORAUT–RPRT–0044 

(‘‘Analysis of Bioassay Data with a 

Significant Fraction of Less-Than 

Results’’), OCAS TIB–0013 (‘‘Special 

External Dose Reconstruction 

Considerations for Mallinckrodt 

Workers’’), OTIB–014 (‘‘Rocky Flats 

Internal Dosimetry Co-Worker 

Extension’’), OTIB–019 (‘‘Analysis of 

Coworker Bioassay Data for Internal 

Dose Assignment’’), OTIB–0029 

(‘‘Internal Dosimetry Coworker Data for 

Y–12’’), OTIB–0047 (External Radiation 

Monitoring at the Y–12 Facility During 

the 1948–1949 Period’’), OTIB–0049 

(‘‘Estimating Doses for Plutonium 

Strongly Retained in the Lung’’), OTIB– 

0052 (‘‘Parameters to Consider When 

Processing Claims for Construction 

Trade Workers’’), OTIB–0054 (‘‘Fission 

and Activation Product Assignment for 

Internal Dose-Related Gross Beta and 

Gross Gamma Analyses’’), and OTIB– 

0070 (‘‘Dose Reconstruction During 

Residual Radioactivity Periods at 

Atomic Weapons Employer Facilities’’); 

and a continuation of the commentresolution process for other dose 

reconstruction procedures under review 

by the Subcommittee. 

The agenda is subject to change as 

priorities dictate. 

This meeting is open to the public, 

but without a public comment period. 


emcdonald on DSK2BSOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 242 / Friday, December 17, 2010 / Notices 78999 

In the event an individual wishes to 

provide comments, written comments 

may be submitted. Any written 

comments received will be provided at 

the meeting and should be submitted to 

the contact person below in advance of 

the meeting. 

Contact Person for More Information: 

Theodore Katz, Executive Secretary, 

NIOSH, CDC, 1600 Clifton Road, 

Mailstop E–20, Atlanta, GA 30333, 

Telephone (513) 533–6800, Toll Free 1 

(800) CDC–INFO, E-mail dcas@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 13, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–31784 Filed 12–16–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Maternal 

Vitamin D Status and Preterm Birth, 

DP11–002, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 11 a.m.–5 p.m., April 1, 

2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Maternal Vitamin D Status and 

Preterm Birth, DP11–002, initial review.’’ 

Contact Person for More Information: 

Donald Blackman, PhD, Scientific Review 

Officer, CDC, National Center for Chronic 

Disease Prevention and Health Promotion, 

Office of the Director, Extramural Research 

Program Office, 4770 Buford Highway, NE., 

Mailstop K–92, Atlanta, GA 30341, 

Telephone: (770) 488–3023, E-mail: 

DBY7@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 13, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–31781 Filed 12–16–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Centers for 

Autism and Developmental Disabilities 

Research and Epidemiology 

(CADDRE), Funding Opportunity 

Announcement (FOA) DD11–002, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 10 a.m.–5 p.m., March 10, 

2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Centers for Autism and 

Developmental Disabilities Research and 

Epidemiology (CADDRE), FOA DD11–002.’’ 

Contact Person for More Information: 

Donald Blackman, PhD, Scientific Review 

Officer, Extramural Research Program Office, 

National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 4770 

Buford Highway, NE., Mailstop K–92, 

Atlanta, Georgia 30341, Telephone: (770) 

488–3023, e-mail: DBY7@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 13, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–31778 Filed 12–16–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–18F5 and 

CMS–R–26] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Application for 

Hospital Insurance; Use: Individuals 

who are not entitled to or eligible for 

railroad retirement board (RRB) or 

Social Security Administration benefits 

must file an application for Part A. This 

group includes individuals who defer 

filing an application for monthly 

benefits, individuals who are 

transitionally insured, government 

employees who pay only the Hospital 

Insurance portion of the Federal 

Insurance Contributions Act tax and 

individuals eligible for Premium Part A 

for the Working Disabled. The 

Application for Hospital InsuranceCMS–18F5 was designed to capture all 

the information needed to make a 

determination of an individual’s 


emcdonald on DSK2BSOYB1PROD with NOTICES